tirzepatide and estrogen Women taking hormone therapy lost 35% more weight on than women taking the drug alone. A Mayo Clinic study published in The Lancet this year — most women on GLP-1s Tirzepatide plus hormone therapy increases

Dihexa Peptide: Benefits, Mechanism, and Cognitive Risks Explained

Eli Lilly may price it at a premium given the superior efficacy data, or may price it competitively to capture market share from Novo Nordisk

It excluded people taking GLP-1 drugs for diabetes, as their use is driven by a medical condition rather than weight loss demand

For example, Ozempic lawsuits say the drug can cause stomach paralysis as well as NAION vision loss

However, insulin injections do not fix the underlying problems that contribute to diabetes

Thiazolidinediones may cause slight weight gain but decrease "pathologic" abdominal fat (visceral fat), and therefore may be prescribed for diabetics with central obesity